Fibricor (U.S. Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Fibricor (U.S. Rights) General Information

Description

The distribution and production rights of a therapy drug. The drug is used as adjunctive therapy to diet for treatment of severe hyperglycemia and as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1 Commerce Drive
  • Cranbury, NJ 08512
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Pharmaceuticals
Corporate Office
  • 1 Commerce Drive
  • Cranbury, NJ 08512
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fibricor (U.S. Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fibricor (U.S. Rights)‘s full profile, request access.

Request a free trial

Fibricor (U.S. Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fibricor (U.S. Rights)‘s full profile, request access.

Request a free trial

Fibricor (U.S. Rights) FAQs

  • Where is Fibricor (U.S. Rights) headquartered?

    Fibricor (U.S. Rights) is headquartered in Cranbury, NJ.

  • What industry is Fibricor (U.S. Rights) in?

    Fibricor (U.S. Rights)’s primary industry is Buildings and Property.

  • Is Fibricor (U.S. Rights) a private or public company?

    Fibricor (U.S. Rights) is a Private company.

  • What is the current valuation of Fibricor (U.S. Rights)?

    The current valuation of Fibricor (U.S. Rights) is .

  • What is Fibricor (U.S. Rights)’s current revenue?

    The current revenue for Fibricor (U.S. Rights) is .

  • Who are Fibricor (U.S. Rights)’s investors?

    Sun Pharmaceutical Industries has invested in Fibricor (U.S. Rights).

  • When was Fibricor (U.S. Rights) acquired?

    Fibricor (U.S. Rights) was acquired on 21-May-2015.

  • Who acquired Fibricor (U.S. Rights)?

    Fibricor (U.S. Rights) was acquired by Tribute Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process